WEBPORTAL
-
Staying focused on Rare Diseases
At ARCHIMEDlife, our focus continues to be on Rare Diseases and special diagnostics. Since March 2020, COVID-19 has challenged us all both personally and professionally.… Read more
-
Advanced diagnostics for Mucopolysaccharidoses
Mucopolysaccharidoses (MPSs) are a group of inherited lysosomal storage disorders affecting lysosomal metabolism. MPSs result in the accumulation of glycosaminoglycans in the body and can… Read more
-
Diagnostic Strategy for Females Suspected of Fabry Disease
Fabry disease (FD) is a X-linked inherited disorder where deficiency of the α-Galactosidase A (α-Gal A) enzyme causes Globotriaosylceramide (GL-3/Gb3) lipid accumulation in the cells… Read more
-
Hemoglobinopathies and β-Thalassemia: Investigating High-Res Mass Spectrometry
Early diagnosis of hemoglobin disorders and Thalassemias are become more important due to a high carrier frequency and ease of global migration. In a prospective… Read more
-
SSIEM 2019 in Rotterdam
ARCHIMEDlife News August 27, 2019Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time presenting at SSIEM, 3 – 6… Read more -
New cut-offs for lysosomal enzyme activities.
ARCHIMEDlife News June 6, 2019We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal enzyme activities from Dried Blood Spots… Read more